Clinical trial
Calcium Supplementation in Postmenopausal Women
NCT00172172 · Shire, Industry · Completed
Key facts
| NCT number | NCT00172172 |
|---|---|
| Title | Calcium Supplementation in Postmenopausal Women |
| Official title | A Study to Evaluate the Effects of Calcium Supplementation on the Efficacy and Safety of Recombinant Human Parathyroid Hormone (ALX1-11) in Postmenopausal Women With Osteoporosis (CAP Study) |
| Acronym | CAP |
| Lead sponsor | Shire, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Osteoporosis |
| Intervention type | Drug |
| Interventions | PTH/Calcium, PTH/placebo, placebo |
| Enrollment | 374 |
| Start date | Jan 10, 2004 |
| Primary completion | Mar 11, 2005 |
| Completion | Mar 11, 2005 |
| First posted | Sep 15, 2005 |
| Last update posted | May 25, 2021 |
| Countries | Argentina, Mexico, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: